




Searching News Database: Vessix Vascular
HSMN NewsFeed - 1 May 2012
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
HSMN NewsFeed - 12 Apr 2012
Vessix Vascular Names Michael D. Gioffredi Chief Commercialization Officer
Vessix Vascular Names Michael D. Gioffredi Chief Commercialization Officer
HSMN NewsFeed - 24 Jan 2012
LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors
LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors